Docoh
Loading...

46 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q3
PRPO Precipio Inc
12 Nov 21
Quarterly report
4:02pm
Our customers are oncologists, hospitals, reference laboratories, physician-office laboratories, and pharma and biotech companies. Customers that accounted for 10% or greater of our net sales or accounts receivable for the identified periods is as follows:
Net salesAccounts receivable, as of
Three Months EndedNine Months Ended
September 30,September 30,September 30,December 31,
202120202021202020212020
Customer A****22%*
* represents less than 10%
10-Q
2021 Q2
PRPO Precipio Inc
12 Aug 21
Quarterly report
4:07pm
Our customers are oncologists, hospitals, reference laboratories, physician-office laboratories, and pharma and biotech companies. Customers that accounted for 10% or greater of our net sales or accounts receivable for the identified periods is as follows:
Net salesAccounts receivable, as of
Three Months EndedSix Months Ended
June 30,June 30,June 30,December 31,
202120202021202020212020
Customer A10%12%*11%**
Customer B*11%****
Customer C***13%**
Customer D****11%*
Customer E****12%*
* represents less than 10%
10-Q
2021 Q1
PRPO Precipio Inc
14 May 21
Quarterly report
4:01pm
Our customers are oncologists, hospitals, reference laboratories, physician-office laboratories, and pharma and biotech companies. Customers that accounted for 10% or greater of our net sales or accounts receivable for the identified periods is as follows:
Net salesAccounts receivable, as of
Three Months Ended
March 31,March 31,December 31,
2021202020212020
Customer A*27%**
Customer B*10%**
Customer C**11%*
* represents less than 10%
10-K
2020 FY
PRPO Precipio Inc
29 Mar 21
Annual report
4:29pm
We are reimbursed by payers for services we provide. Payments for services covered by payers average less than billed charges. We monitor revenue and receivables from payers and record an estimated contractual allowance for certain revenue and receivable balances as of the revenue recognition date to properly account for anticipated differences between amounts estimated in our billing system and amounts ultimately reimbursed by payers. Accordingly, the total revenue and receivables reported in our consolidated financial statements are recorded at the amounts expected to be received from these payers. For service revenue, the contractual allowance is estimated based on several criteria, including unbilled claims, historical trends based on actual claims paid, current contract and reimbursement terms and changes in customer base and payer/product mix. The billing functions for the remaining portion of our revenue are contracted and fixed fees for specific services and are recorded without an allowance for contractual discounts. The following table presents our revenues initially recognized for each associated payer class during the years ended December 31, 2020 and 2019.
(dollars in thousands)Contractual Allowances andRevenues, net of Contractual
Gross RevenuesadjustmentsAllowances and adjustments
202020192020201920202019
Medicaid$53$31$$(3)$53$28
Medicare2,8821,686(17)2,8821,669
Self-pay41134(3)40834
Third party payers11,8915,785(8,449)(4,060)3,4421,725
Contract diagnostics426595426595
15,6638,131(8,452)(4,080)7,2114,051
Clinical research grants and other2204422044
$15,883$8,175$(8,452)$(4,080)$7,431$4,095
10-K
2020 FY
PRPO Precipio Inc
29 Mar 21
Annual report
4:29pm
Customer revenue and accounts receivable concentration amounted to the following for the identified periods.
Net salesAccounts receivable, as of
Years Ended
December 31,December 31,December 31,
2020201920202019
Customer A*19%**
Customer B*11%*17%
Customer C***12%
* represents less than 10%
10-K
utiyf ivv
29 Mar 21
Annual report
4:29pm
10-K
du4azmp3e469k8hh5d4
29 Mar 21
Annual report
4:29pm
10-Q
sfxvm0zfk4rsyxc2fl3t
13 Nov 20
Quarterly report
4:01pm
10-Q
zzyod
13 Aug 20
Quarterly report
3:07pm
10-Q
cd8z1yz
13 Aug 20
Quarterly report
3:07pm
10-Q
on0ktlv6
14 May 20
Quarterly report
4:05pm
10-Q
40fuqth292ydrb92do
14 May 20
Quarterly report
4:05pm
10-K
y1r4m
27 Mar 20
Annual report
3:47pm
10-K
fn8bh fankglwwskhm
27 Mar 20
Annual report
3:47pm
10-K
ve1l8d0fx8t5m340ko
27 Mar 20
Annual report
3:47pm
10-K
iginrzjs50xncyscg8w
27 Mar 20
Annual report
3:47pm
10-K
ne087xdfjekh
27 Mar 20
Annual report
3:47pm
10-Q
xkb dbr672
13 Nov 19
Quarterly report
4:33pm
10-Q
pyxks99pro3ox
13 Nov 19
Quarterly report
4:33pm
10-Q
pkso2h
13 Nov 19
Quarterly report
4:33pm